These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 14269

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Laboratory and clinical evaluation of clindamycin-2-palmitate in pediatric field (author's transl)].
    Fujii R, Konno M, Ubukata K, Sakuma A.
    Jpn J Antibiot; 1973 Dec; 26(6):545-61. PubMed ID: 4150085
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Clinical application of clindamycin-2-phosphate (author's transl)].
    Nakagawa K, Watanabe K, Kabe J, Kihara N.
    Jpn J Antibiot; 1977 Jan; 30(1):36-8. PubMed ID: 839642
    [No Abstract] [Full Text] [Related]

  • 29. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA.
    Scand J Infect Dis Suppl; 1984 Jan; 43():62-6. PubMed ID: 6598522
    [Abstract] [Full Text] [Related]

  • 30. Clindamycin in infective endocarditis.
    Cherubin CE, Nair SR.
    JAMA; 1978 Feb 13; 239(7):626-7. PubMed ID: 563932
    [Abstract] [Full Text] [Related]

  • 31. [Basic and clinical studies on clindamycin for intravenous injection (author's transl)].
    Imaoka M, Uzuka Y, Noguchi Y, Watanabe K, Matsumoto K.
    Jpn J Antibiot; 1977 Jan 13; 30(1):51-8. PubMed ID: 839644
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Clinical studies on clindamycin-2-palmitate (author's transl)].
    Kobayashi Y, Akaishi K, Nishio T, Kobayashi Y.
    Jpn J Antibiot; 1973 Aug 13; 26(4):365-76. PubMed ID: 4147527
    [No Abstract] [Full Text] [Related]

  • 36. [Therapy for severe anaerobic infections with clindamycin (author's transl)].
    Kobayasi A, Sato S, Ito T, Utsumi T, Kikuchi N.
    Jpn J Antibiot; 1977 Jan 13; 30(1):13-21. PubMed ID: 839638
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Potential clindamycin resistance in clindamycin-susceptible, erythromycin-resistant Staphylococcus aureus: report of a clinical failure.
    Levin TP, Suh B, Axelrod P, Truant AL, Fekete T.
    Antimicrob Agents Chemother; 2005 Mar 13; 49(3):1222-4. PubMed ID: 15728934
    [Abstract] [Full Text] [Related]

  • 39. Parenteral clindamycin phosphate: pharmacology with normal and abnormal liver function and effect on nasal staphylococci.
    Williams DN, Crossley K, Hoffman C, Sabath LD.
    Antimicrob Agents Chemother; 1975 Feb 13; 7(2):153-8. PubMed ID: 1137366
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.